Physician profile
Jerry A Simpson
NPI 1861484016
$2,523.94
in general payments reported to CMS, 2019-2025
22 companies · $69.10 in 2025
The $69.10 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $124 · 2021: $105 · 2022: $300 · 2023: $706 · 2024: $702 · 2025: $69.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,464 · Education: $13.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,463.97 |
| Education | $13.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $601.83 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $555.85 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $297.91 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $153.94 | 2019-2023 | Farxiga, Brilinta |
| Pfizer INC. | $132.14 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $127.66 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $125.75 | 2019-2025 | |
| Irhythm Technologies, INC. | $78.13 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $71.63 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.55 | 2019-2020 | |
| United Therapeutics Corporation | $52.07 | 2019 | |
| Boston Scientific Corporation | $49.24 | 2021-2023 | Watchman Flx |
| Amarin Pharma, INC. | $36.42 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.80 | 2024-2025 | Jardiance |
| Scpharmaceuticals INC. | $30.61 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $24.80 | 2024 | Arcalyst |
| Medtronic, INC. | $22.00 | 2024 | Corevalve Evolut R |
| Daiichi Sankyo INC. | $19.32 | 2023 | Injectafer |
| Astellas Pharma US INC | $18.41 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $14.87 | 2023 | Evkeeza |
| Kowa Pharmaceuticals America, INC. | $12.91 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.